The Latest Regenerative Medicine Articles from Streetwise Reports
Regenerative Medicine Firm Reports Positive Chronic Lower Back Pain Trial Results
Research Report
New study data and next steps for Mesoblast's MPC-06-ID are presented in a Dawson James Securities report.
read more >
Analyst: Differences Between Two Possible COVID-19 Therapies Noteworthy
Research Report
The factors that set Athersys' stem cell product MultiStem apart from a competitor's therapeutic are provided in a Dawson James Securities report.
read more >
Showing Results: 1 to 2 of 2